Recipient age and mycophenolate mofetil as the main determinants of outcome after steroid withdrawal: Analysis of long-term follow-up in renal transplantation

Transplantation

Volumn 80, Issue 6, 2005, Pages 872-874

  Laouad, Inass ^a   Halimi, Jean Michel ^a,b   Büchler, Matthias ^a   Al Najjar, Azmi ^a   Chatelet, Valérie ^a   Nivet, Hubert ^a   Lebranchu, Yvon ^a  

^a UNIVERSITÉ DE TOURS   (France)

^b CHU BRETONNEAU   (France)

Author keywords

Age; Graft survival; Mycophenolate mofetil; Rejection; Renal transplantation; Steroid withdrawal

Indexed keywords

MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; THYMOCYTE ANTIBODY;

ADULT; AGE; ARTICLE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; INCIDENCE; KIDNEY TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; STEROID THERAPY; SURVIVAL RATE;

ADULT; AGING; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MYCOPHENOLIC ACID; RISK FACTORS; STEROIDS; TIME FACTORS; TREATMENT OUTCOME;

EID: 26644456939     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000173824.22834.A1     Document Type: Article

References (20)

1. Vincenti F. A decade of progress in kidney transplantation. Transplantation 2004; 77: S52.
2. Schulak JA. Steroid immunosuppression in kidney transplantation: a passing era. J Surg Res 2004; 117: 154.
3. Ter Meulen CG, van Riemsdijk I, Hené RJ, et al. Steroid-withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: a prospective, randomized, multicenter study. Am J Transplant 2004; 4: 803.
4. Vincenti F, Monaco A, Grinyo J, et al. Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil. Am J Transplant 2003; 3: 306.
5. Khwaja K, Asolati M, Harmon J, et al. Outcome at 3 years with a prednisone-free maintenance therapy regimen: a single-center experience with 349 kidney transplant recipients. Am J Transplant 2004; 4: 980.
6. EBPG Expert Group on Renal Transplantation. Section IV: Long-term management of the transplant recipient. Nephrol Dial Transplant 2002; 17 Suppl 4: 1.
7. Smak Gregoor PJH, De Sévaux RGL, Ligtenberg G, et al. Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy, a randomized, prospective, multicenter study. J Am Soc Nephrol 2003; 13: 1365.
8. Hricik DE, Knauss TC, Bodziak KA, et al. Withdrawal of steroid therapy in African American kidney transplant recipients receiving sirolimus and tacrolimus. Transplantation 2003; 76: 938.
9. Opelz G. Effect of the maintenance immunosuppressive drug regimen on kidney transplant outcome. Transplantation 1994; 58: 443.
10. Vanrenterghem Y, Lebranchu Y, Hené R, et al. Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection. Transplantation 2000; 70: 1352.
11. Ratcliffe PJ, Dudley CRK, Higgins RM, et al. Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Lancet 1996; 348: 643.
12. Kasiske BL, Chakkera HA, Louis TA, Ma JZ. A meta-analysis of immunosuppression in cyclosporine treated renal transplant recipients: a meta-analysis. J Am Soc Nephrol 2000; 1: 1910.
13. Sinclair NRS for Canadian Multicenter Transplant Study Group. Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. Can Med Assoc J 1992; 1: 645.
14. Hollander AMJ, Hene RJ, Hermans J, et al. Late prednisone withdrawal in cyclosporine-treated kidney transplant patients: a randomized study. J Am Soc Nephrol 1997; 8: 294.
15. Squiflet JP, Vanrenterghem Y, van Hooff JP, et al. Safe withdrawal of corticosteroids or MMF: results of a large, prospective, multicenter, randomized study. Transplant Proc 2002; 34: 1584.
16. Ghandour FZ, Knauss TC, Mulligan DC, et al. Influence of steroid withdrawal on proteinuria in renal allograft recipients. Clin Transplant 1997; 11: 395.
17. Siddiqi N, McBride M, Hariharan S. Similar risk profiles for post-transplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis. Transplantation 2004; 65: 1906.
18. Heim-Duthoy KL, Chitwood KK, Tortorice KL, et al. Elective cyclosporine withdrawal 1 year after renal transplantation. Am J Kidney Dis 1994; 24: 846.
19. Meier-Kriesche HU, Ojo A, Hanson J, et al. Increased immunosuppressive vulnerability in elderly renal transplant recipients. Transplantation 2000; 69: 885.
20. Hricik DE, Seliga RM, Fleming-Brooks S, et al. Determinants of long-term allograft function following steroid withdrawal in renal transplant recipients. Clin Transplant 1995; 9: 419.